Cerner Provides Access to De-Identified Patient Data for COVID-19 Research

Published on: 

Applied Clinical Trials

Cerner Corporation is offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic. The offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials, and medical treatments related to COVID-19. The de-identified patient data secured on Cerner HealtheDataLab, powered by Amazon Web Services Inc. will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, lab results, clinical complications, and more that could help drive medical decisions. 

For more information, click here.